Publications

  1. Wadei HM, Bulatao IG, Gonwa TA, Mai ML, Prendergast M, Keaveny AP, Rosser BG, Taner CB. Inferior long term outcome of liver-kidney transplantation from donation after cardiac death donors: Single center and OPTN analyses. Liver Transpl. 2014 Mar 20. [Epub ahead of print]
    View PubMed
  2. Yataco ML, Difato T, Bargehr J, Rosser BG, Patel T, Trejo-Gutierrez JF, Pungpapong S, Taner CB, Aranda-Michel J. Reversible non-ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single-centre experience. Liver Int. 2014 Feb 16.
    View PubMed
  3. Bargehr J, Trejo-Gutierrez JF, Rosser BG, Patel T, Yataco ML, Pungpapong S, Taner CB, Aranda-Michel J. Liver transplantation in patients with atrial fibrillation. Transplant Proc. 2013 Jul-Aug; 45(6):2302-6.
    View PubMed
  4. Pungpapong S, Aqel BA, Koning L, Murphy JL, Henry TM, Ryland KL, Yataco ML, Satyanarayana R, Rosser BG, Vargas HE, Charlton MR, Keaveny AP. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl. 2013 Jul; 19(7):690-700. Epub 2013 Jun 03.
    View PubMed
  5. Sibulesky L, Heckman MG, Taner CB, Canabal JM, Diehl NN, Perry DK, Willingham DL, Pungpapong S, Rosser BG, Kramer DJ, Nguyen JH. Outcomes following liver transplantation in intensive care unit patients. World J Hepatol. 2013 Jan 27; 5(1):26-32.
    View PubMed
  6. Taner CB, Bulatao IG, Arasi LC, Perry DK, Willingham DL, Sibulesky L, Rosser BG, Canabal JM, Nguyen JH, Kramer DJ. Liver transplantation in the critically ill: donation after cardiac death compared to donation after brain death grafts. Ann Hepatol. 2012 Sep-Oct; 11(5):679-85.
    View PubMed
  7. Wadei HM, Zaky ZS, Keaveny AP, Rosser B, Jones M, Mai ML, Bulatao I, Gonwa TA. Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients. Transplantation. 2012 May 27; 93(10):1006-12.
    View PubMed
  8. Taner CB, Ung RL, Rosser BG, Aranda-Michel J. Age is not a contraindication for orthotopic liver transplantation: a single institution experience with recipients older than 75 years. Hepatol Int. 2012 Jan; 6(1):403-7. Epub 2011 Jun 18
    View PubMed
  9. Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl. 2011 Jun; 17(6):641-9.
    View PubMed
  10. Taner CB, Balci D, Willingham DL, Keaveny AP, Rosser BG, Canabal JM, Shine TS, Harnois DM, Kramer DJ, Nguyen JH. Long-term outcomes after third liver transplant. Exp Clin Transplant. 2011 Apr; 9(2):98-104.
    View PubMed
  11. Hughes CB, Dickson RC, Krishna M, Willingham DL, Satyanarayana R, Harnois DM, Keaveny AP, Rosser B, Aranda-Michel J, Kramer DJ, Hellinger W, Mendez J. HCV recurrence in HIV-infected patients after liver transplant. J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr; 9(2):87-93. Epub 2010 Mar 31.
    View PubMed
  12. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, Rosser BG, Keaveny AP, Aranda-Michel J, Satyanarayana R, Harnois D, Dickson RC, Kramer DJ, Hughes CB. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009 Sep; 15(9):1028-35.
    View PubMed
  13. Nguyen JH, Bonatti H, Dickson RC, Hewitt WR, Grewal HP, Willingham DL, Harnois DM, Schmitt TM, Machicao VI, Ghabril MS, Keaveny AP, Aranda-Michel J, Satyanarayana R, Rosser BG, Hinder RA, Steers JL, Hughes CB. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant. 2009 Mar-Apr; 23(2):168-73. Epub 2009 Feb 11.
    View PubMed
  14. Wadei HM, Geiger XJ, Cortese C, Mai ML, Kramer DJ, Rosser BG, Keaveny AP, Willingham DL, Ahsan N, Gonwa TA. Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transplant. 2008 Dec; 8(12):2618-26.
    View PubMed
  15. Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl. 2007 Dec; 13(12):1717-27.
    View PubMed
  16. Ghabril M, Nguyen J, Kramer D, Genco T, Mai M, Rosser BG. Presentation of an acquired urea cycle disorder post liver transplantation. Liver Transpl. 2007 Dec; 13(12):1714-6.
    View PubMed
  17. Pungpapong S, Alvarez S, Hellinger WC, Kramer DJ, Willingham DL, Mendez JC, Nguyen JH, Hewitt WR, Aranda-Michel J, Harnois DM, Rosser BG, Hughes CB, Grewal HP, Satyanarayana R, Dickson RC, Steers JL, Keaveny AP. Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome. Liver Transpl. 2006 Aug; 12(8):1244-52.
    View PubMed
  18. Krishna M, Keaveny AP, Genco PV, Rosser BG, Dickson RC, Nguyen JH, Steers JL, Nakhleh RE. Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis. Transplant Proc. 2005 Jun; 37(5):2221-3.
    View PubMed
  19. Nakhleh RE, Krishna M, Keaveny AP, Dickson RC, Rosser B, Nguyen JH, Steers JL. Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence. Transplant Proc. 2005 Mar; 37(2):1240-2.
    View PubMed
  20. Ward EM, Raimondo M, Rosser BG, Wallace MB, Dickson RD. Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation. J Clin Gastroenterol. 2004 Nov-Dec; 38(10):898-900.
    View PubMed
  21. Aqel BA, Machicao V, Rosser B, Satyanarayana R, Harnois DM, Dickson RC. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. J Clin Gastroenterol. 2004 Oct; 38(9):805-9.
    View PubMed
  22. Machicao VI, Krishna M, Bonatti H, Aqel BA, Nguyen JH, Weigand SD, Rosser BG, Hughes C, Dickson RC. Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation. Liver Transpl. 2004 May; 10(5):599-606.
    View PubMed
  23. Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation. 2004 Jan 15; 77(1):84-92.
    View PubMed
  24. Abosh D, Rosser BG, Kaita KDE, Bazylewski R, Minuk GY. Outcomes following liver transplantation for patients with alcohol versus nonalcoholic-induced liver disease. Canadian Journal of Gastroenterology. 2000 Nov; 14(10):851-5.
    View PubMed
  25. Assy N, Kaita KDE, Mymin D, Levy CS, Rosser BG, Minuk GY. Fatty infiltration of liver in hyperlipidemic patients. Digestive Diseases and Sciences. 2000 Oct; 45(10):1929-34.
    View PubMed
  26. Fallows G, Kaita K, Minuk GY, Penner F, Smart G, Dawood M, Rosser BG. Early changes in HCV-RNA levels predict response to Interferon treatment in non-cirrhotic HCV patients. Canadian journal of Gastroenterology. 2000 Jul/August; 14(Suppl B):30B-5B.
    View PubMed
  27. Minuk GY, Cohen AJ, Burczynski FJ, Rosser BG, Lipschitz J. The effects of various organ preservation solutions on hepatocyte membrane potentials, intracellular calcium concentrations and outcome following liver transplantation. American Journal of Surgery. 2000 Feb; 179(2):154-60.
    View PubMed
  28. Gonzalez B, Chappell C, Rosser BG. Glycochenodeoxycholate (GCDC) induced hepatocyte apoptosis is associated with early modulation of intracellular PKC activity. Molecular and Cellular Biochemistry. 2000; 207(1&2):19-27.
    View PubMed
  29. Assy N, Rosser BG, Grahmae GR, Minuk GY. The risk of sedation for upper gastrointestinal endoscopy exacerbating sub clinical hepatic encephalopathy in patients with cirrhosis. Gastrointestinal Endoscopy. 1999 Jun; 49(6):690-4G.
    View PubMed
  30. Burczynski FJ, Wang GQ, Zhang MN, Pavletic P, Laita K, Minuk GY, Rosser BG. Membrane potential of hepatocytes in intact liver and those isolated from normal and cirrhotic animals. Journal of Hepatology. 1999 Mar; 30(3):492-7.
    View PubMed
  31. Kaita KDE, Roberts D, Rosser BG, Minuk GY. An institutional review of fulminant hepatic failure in an urban Canadian centre. Hepatology Research. 1998; 11:115-24.
  32. Bazylewski R, Rosser BG, Cohen A, Kaita KDE, Minuk GY. Profile of a liver transplant follow-up clinic in a nontransplant Canadian urban center. Canadian Journal of Gastroenterology. 1997 Apr; 11(3):235-8.
    View PubMed
  33. Rosser BG, Poterucha JJ, McKusick MA, Kamath PS. Thoracic duct-cutaneous fistula in a patient with cirrhosis of the liver: successful treatment with a transjugular intrahepatic portosystemic shunt. Mayo Clin Proc. 1996 Aug; 71(8):793-6.
    View PubMed
  34. Rosser BG, Gores GJ. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology. 1995 Jan; 108(1):252-75.
    View PubMed
  35. Minuk GY, Wong WWS, Kaita KDE, Rosser BG. Risk factors of hepatitis C infection in Canadian patients with chronic type C hepatitis. Canadian Journal of Gastroenterology. 1995; 9(3):137-40.
  36. Rosser BG, Powers SP, Gores GJ. Calpain activity increases in hepatocytes following addition of ATP. Demonstration by a novel fluorescent approach. J Biol Chem. 1993 Nov 5; 268(31):23593-600.
    View PubMed